Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights Broadcom, Johnson & Johnson, Verizon, Taylor Devices and Frequency Electronics

Read MoreHide Full Article

For Immediate Releases

Chicago, IL – June 11, 2024 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Broadcom Inc. (AVGO - Free Report) , Johnson & Johnson (JNJ - Free Report) and Verizon Communications Inc. (VZ - Free Report) , Taylor Devices, Inc. (TAYD - Free Report) and Frequency Electronics, Inc. (FEIM - Free Report) .

Here are highlights from Monday’s Analyst Blog:

Earnings Season Update and Analyst Reports for Broadcom, J&J and Verizon

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features an update on the earnings season and updated analyst reports on 16 major stocks, including Broadcom Inc., Johnson & Johnson and Verizon Communications Inc., as well as two micro-cap stocks Taylor Devices, Inc. and Frequency Electronics, Inc. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.

These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Earnings Season Update

The Q2 earnings season will really get going on July 12th when JPMorgan comes out with its quarterly results. But the reporting cycle actually gets underway before that when companies with fiscal quarters ending in May report their results. In fact, the recent results from Costco and AutoZone for their fiscal quarters ending in May will get counted as part of the 2024 Q2 tally.

Total S&P 500 earnings for Q2 are expected to be up +8.6% from the same period last year on +4.6% higher revenues. Estimates have held up really well, compared to other recent periods.

The +8.6% earnings growth expected for Q2 today is down from +8.8% at the start of April. Estimates inched up through the end of April, but started coming down a bit in May and since then. All in all, Q2 earnings estimates have held up a lot better relative to what we have seen in other recent periods.

Today's Featured Research Reports

Broadcom shares have outperformed the Zacks Electronics - Semiconductors industry over the year-to-date period (+26.6% vs. +16.0%). The company is benefiting from the robust adoption of AI and the strong deployment of generative AI. In the first quarter of 2024, under its semiconductor segment, AI revenues quadrupled year over year to $2.3 billion despite sluggish enterprise and telcos end markets.

Broadcom now expects fiscal 2024 AI revenues of roughly $10 billion. Networking revenues are expected to rally 35% year over year, driven by the accelerating deployment of networking connectivity and the expansion of AI accelerators within hyperscalers.

Broadcom expects continued strong bookings at VMware will accelerate revenue growth through the rest of fiscal 2024. VMware revenues are expected to grow double-digit percentage sequentially through the rest of the fiscal year. However, it expects flat growth in wireless segment.

(You can read the full research report on Broadcom here >>>)

Shares of Johnson & Johnson have underperformed the Zacks Large Cap Pharmaceuticals industry over the year-to-date period (-4.6% vs. +21.5%). The company is facing headwinds like generic competition and pricing pressure. J&J faces the upcoming patent expiration of Stelara. Though it has taken meaningful steps to resolve its talc and opioid litigation, uncertainty regarding the talc litigations persists.

Nevertheless, J&J’s Innovative Medicine unit is performing at above-market levels. Its growth is being driven by existing products like Darzalex, Stelara, Tremfya and Erleada, and also the continued uptake of new launches, including Spravato, Carvykti and Tecvayli.

The MedTech unit is showing improving trends, driven by a recovery in surgical procedures and contribution from new products. J&J is making rapid progress with its pipeline and line extensions.

(You can read the full research report on Johnson & Johnson here >>>)

Verizon shares have gained +23.6% over the past year against the Zacks Wireless National industry’s gain of +27.9%. The company is offering various mix and match pricing in both wireless and home broadband plans, which has led to solid client additions. Focus on emerging growth services like cloud, security and professional services will likely reap long-term benefits.

The deployment of a cloud-native, container-based, virtualized architecture has led to higher flexibility, scalability and cost efficiency across its network. It is likely to benefit from customer-focused planning, disciplined engineering and steady investments for a comprehensive service portfolio.

However, lower wireline and wireless equipment revenues are major concerns. Huge promotional expenses and lucrative discounts to expand customer base are weighing on margins. High capital expenditure for continuous network upgrade and fiber deployment is a headwind. A muted guidance for 2024 is worrisome.

(You can read the full research report on Verizon here >>>)

Shares of Taylor Devices have outperformed the Zacks Manufacturing - General Industrial industry over the year-to-date period (+112.0% vs. +3.1%). This microcap company with market capitalization of $165.22 million has shown strong financial performance. Sales in the aerospace/defense sector jumped by 88%, offsetting declines in other sectors and highlighting strategic realignment toward profitable segments.

Gross profit margins improved to 46% from 41%, reflecting enhanced operational efficiency and cost management. The company boasts solid liquidity with $3.1 million in cash and short-term investments, underpinning financial stability and strategic initiative support. A positive $30.2 million order backlog indicates future revenue visibility.

However, reliance on the aerospace/defense sector poses risks, while rising SG&A expenses could impact future growth.

(You can read the full research report on Taylor Devices here >>>)

Frequency Electronics’ shares have outperformed the Zacks Instruments - Control industry over the past year (+45.1% vs. +22.1%). This microcap company with market capitalization of $88.66 million shows strong investment potential with 42.9% revenue growth, from $27.8 million to $39.7 million for the nine months ended Jan 31, 2024, driven by increased sales in government and commercial sectors, particularly in satellite and communication technologies.

The company's strategic positioning in markets with high barriers to entry, like precision time and frequency control products essential for defense and communication, ensures stable revenue streams and long-term contracts. Operational efficiencies have also improved, with cost reductions boosting gross margins from 13.7% to 31%.

The company maintains healthy liquidity. However, significant reliance on U.S. Government contracts poses risks due to political and budgetary uncertainties. Stringent regulatory requirements and global political tensions present risks.

(You can read the full research report on Frequency Electronics here >>>)

Why Haven’t You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.

Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339                                                                              


Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit  for information about the performance numbers displayed in this press release.

Published in